References
Furman JL, Chiu M, Hunter MJ. Early engineering approaches to improve peptide developability and manufacturability. AAPS J. 2015;17(1):111–20.
Bak A, Leung D, Barrett SE, Forster S, Minnihan EC, Leithead AW, et al. Physicochemical and formulation developability assessment for therapeutic peptide delivery—a primer. AAPS J. 2015;17(1):144–55.
Di L. Strategic approaches to optimizing peptide ADME properties. AAPS J. 2015;17(1):134–43.
Acknowledgments
The authors would like to acknowledge the speakers in the 2013 symposium, Dr. Li Di, Pfizer, Dr. Michael Hunter, Janssen/Johnson and Johnson, and Dr. Andy Vick, Wil Research for their contributions to the symposium from which the article series on peptide developability was based. We would also like to thank Dr. Li Di, Pfizer, Dr. Jennifer Fuhman, plus other co-authors from Janssen/Johnson and Johnson, and Merck for their contributors to the articles published in The AAPS Journal. Lastly, the authors would like to acknowledge Dr. Caroline McGregor from Merck for comments and editorial help with the manuscript.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Guest Editors: Annette Bak and Weiguo Dai
Rights and permissions
About this article
Cite this article
Bak, A., Dai, W. Peptide Developability at the Discovery-to-Development Interface—Current State and Future Opportunities. AAPS J 17, 777–779 (2015). https://doi.org/10.1208/s12248-015-9755-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1208/s12248-015-9755-3